Purchase Order VA5801N8639
Award Date 8/19/11
Potential Completion Date 9/18/11
Potential Value $7.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Scottsdale, AZ 85257, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the purchase of the Provant Therapy System from Regenesis Biomedical Inc., a medical technology company. The $4,820.98 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) on December 28, 2010, with an ultimate completion date of January 28, 2011. The contract was awarded against Regenesis Biomedical's existing GSA Schedule 65-II-A contract for medical equipment and supplies, and did not utilize any set-aside designations....
- This federal contract award is for the provision of the Provant Therapy System by Regenesis Biomedical Inc. to the Department of Veterans Affairs (VA). The Provant Therapy System is a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract, valued at $10,067.09, is a firm fixed-price purchase order with no set-aside designation. Regenesis Biomedical Inc. acts as the prime contractor, providing the Provant Therapy System...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, for the provision of the Provant Therapy System and related rental services. The contract, valued at $4,820.98, was awarded on a firm fixed-price basis with a completion date of February 20, 2011. It was issued as a purchase order and did not utilize any set-aside designations. Regenesis Biomedical Inc. provides the Provant Therapy System, a...
- This federal contract award to Regenesis Biomedical Inc. is a purchase order valued at $7,055.10 for the company's Provant Therapy System. The contract was awarded by the U.S. Department of Veterans Affairs (VA) under the agency's Medical procurement program. The Provant Therapy System is a non-invasive medical device indicated for the palliative treatment of post-operative pain and edema. Regenesis Biomedical, a for-profit medical device manufacturer, provides the Provant Therapy System to...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 contract is for the Provant Therapy System, a noninvasive regenerative medicine product developed and patented by Regenesis Biomedical. The Provant Therapy System is indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of March 16, 2011. Regenesis...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company. The $7,055.10 firm-fixed-price purchase order is for the provision of the Provant Therapy System, a patented noninvasive regenerative medicine product developed by Regenesis Biomedical. The contract, which does not utilize any set-aside, is awarded against Regenesis Biomedical's GSA Schedule 65-II-A contract for medical equipment and supplies. The...
- This federal contract award, valued at $4,820.98, was issued by the U.S. Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company, for the provision of the company's Provant Therapy System. The Provant Therapy System is a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract was awarded as a Firm Fixed Price purchase order and did not utilize any set-aside designations....
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, for the provision of the Provant Therapy System and related rental services. The $7,142.85 firm-fixed-price purchase order contract, awarded on February 2, 2011, with a completion date of March 2, 2011, was not set aside for any preference program. Regenesis Biomedical Inc. is the prime contractor and is providing its proprietary Provant...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a medical technology company. The $7,055.10 firm-fixed-price purchase order is for the company's Provant Therapy System, a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has no set-aside designation and was awarded on December 16, 2010, with a completion date of January 16, 2011. Regenesis Biomedical, the...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company, for the provision of the Provant Therapy System and related rental services. The $4,820.98 firm fixed-price purchase order contract was awarded on April 21, 2011, with a completion date of May 21, 2011. The contract was issued against Regenesis Biomedical's existing GSA Schedule 65-II-A for medical equipment and supplies, and did not utilize any...